K-numberK243121
Device nameSLT Select Fiber Delivery System and Contact Tips (models: SSRH 8-SMA; TCRH 7-SMA; FEF 2.2-SMA; CFE 0.6-SMA; SSRH 8Z-SMA; SSRH 4-SMA; SSRH 6-SMA; SSRH 9-SMA; SSRH 10-SMA; SSRH 11-SMA; SSRH 7L-SMA; TCRH 7Z-SMA; FEF 1.8-SMA; CFE 0.55-SMA; CFE 0.36-SMA; LAL 550-SMA; LAL 550Z-SMA; LAL 365-SMA; LAL 365Z-SMA; ER2; ERP2; GR2; GRP2; ER4; ERP4; GR4; GRP4; ER6; ERP6; GR6; GRP6; ER8; ERP8; GR8; GRP8; ER10; ERP10; GR10; GRP10; ER12; ERP12; GR12; GRP12; MD2.5; MD3.5; HP1.0; MTP1.5; MTP3.5; MTRG1.5;
ApplicantJiangxi Medex Technology Co., Ltd.
Product codeGEX
Device classClass II
Decision dateDec 22, 2024
DecisionSubstantially Equivalent
Regulation878.4810
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The SLT Select Fiber Delivery System and Contact Tips are optical fiber delivery systems that transmit laser energy (532–1064 nm wavelength) from a laser generator to surgical sites, enabling precise tissue effects including incision, excision, vaporization, and coagulation. The devices are intended for use across multiple surgical specialties including general surgery, urology, gynecology, ENT, neurosurgery, and orthopedics.

Technological characteristics

The proposed device and predicate device are identical in product code, regulation number, indications for use, transmission efficiency, tensile strength of the fiber-to-connector joint, optical fiber tensile strength, minimum bending working radius, optical fiber bending fatigue resistance, and divergence angle. The devices feature a universal SMA-905 connector compatible with lasers operating in continuous wave or quasi-continuous wave mode with numerical aperture ≤0.35.

Test standards cited

Biocompatibility testing was conducted per ISO 10993-5:2009 (in vitro cytotoxicity), ISO 10993-10:2021 (skin sensitization), ISO 10993-23:2021 (intracutaneous reactivity), ISO 10993-11:2017 (pyrogen and acute systemic toxicity). Bench testing and performance validation were performed in accordance with applicable standards.

Substantial equivalence argument

The proposed device is substantially equivalent to the predicate because it shares identical product code, regulatory classification, indications for use, and patient population. Technological comparison demonstrates matching performance across all critical parameters including transmission efficiency, tensile strength, bending radius, fatigue resistance, and divergence angle. Biocompatibility testing confirms compliance with established safety standards, and bench testing confirms performance parity with the predicate device.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →